Paul J. Diaz Elected to Merck & Co., Inc., Rahway, N.J., USA Board of Directors - Yahoo Finance
Paul J. Diaz Elected to Merck & Co., Inc., Rahway, N.J., USA Board of Directors Yahoo Finance
Merck & Co Company News
Merck & Co., Inc. $MRK Stock: State of Alaska Department of Revenue Reduces Stake - MarketBeat
Merck & Co., Inc. $MRK Stock: State of Alaska Department of Revenue Reduces Stake MarketBeat
Nimbus hires Merck & Co dealmaker as chief business officer - The Pharma Letter
Nimbus hires Merck & Co dealmaker as chief business officer The Pharma Letter
Merck & Co’s US antibiotic withdrawal sends the wrong signals for combating resistance - Chemistry World
Merck & Co’s US antibiotic withdrawal sends the wrong signals for combating resistance Chemistry World
Merck & Co. (NYSE:MRK): A Quality Investing Case With Strong ROIC but Revenue Growth Concerns - ChartMill
Merck & Co. (NYSE:MRK): A Quality Investing Case With Strong ROIC but Revenue Growth Concerns ChartMill
Merck & Co Inc Stock (MRK) Moved Up by 3.73% on Oct 14: A Full Analysis - TradingKey
Merck & Co Inc Stock (MRK) Moved Up by 3.73% on Oct 14: A Full Analysis TradingKey
8,527 Shares of Merck & Co., Inc. $MRK Acquired by Neumann Capital Management LLC - MarketBeat
8,527 Shares of Merck & Co., Inc. $MRK Acquired by Neumann Capital Management LLC MarketBeat
Merck & Co., Inc. (MRK) Reports Promising Skin Cancer Trial Results for Keytruda and Personalized mRNA Vaccine - Yahoo Finance
Merck & Co., Inc. (MRK) Reports Promising Skin Cancer Trial Results for Keytruda and Personalized mRNA Vaccine Yahoo Finance
18,326 Merck & Co., Inc. $MRK Shares Sold by Ninety One UK Ltd - MarketBeat
18,326 Merck & Co., Inc. $MRK Shares Sold by Ninety One UK Ltd MarketBeat
Milestone Asset Management LLC Sells 9,248 Shares of Merck & Co., Inc. $MRK - MarketBeat
Milestone Asset Management LLC Sells 9,248 Shares of Merck & Co., Inc. $MRK MarketBeat
1,133,024 Merck & Co., Inc. $MRK Shares Sold by Assenagon Asset Management S.A. - MarketBeat
1,133,024 Merck & Co., Inc. $MRK Shares Sold by Assenagon Asset Management S.A. MarketBeat
VMS Asset Management Limited Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
VMS Asset Management Limited Makes New Investment in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Stock Acquired by Strategy Asset Managers LLC - MarketBeat
Merck & Co., Inc. $MRK Stock Acquired by Strategy Asset Managers LLC MarketBeat
Western Financial Corp CA Acquires 29,043 Shares of Merck & Co., Inc. $MRK - MarketBeat
Western Financial Corp CA Acquires 29,043 Shares of Merck & Co., Inc. $MRK MarketBeat
Curated Wealth Partners LLC Sells 127,541 Shares of Merck & Co., Inc. $MRK - MarketBeat
Curated Wealth Partners LLC Sells 127,541 Shares of Merck & Co., Inc. $MRK MarketBeat
24,447 Shares of Merck & Co., Inc. $MRK Purchased by B.A. Schrock Wealth Management Inc. - MarketBeat
24,447 Shares of Merck & Co., Inc. $MRK Purchased by B.A. Schrock Wealth Management Inc. MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Jumps 3.6% - Still a Buy? - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Jumps 3.6% - Still a Buy? MarketBeat
Merck & Co., Inc. $MRK Stock: Fort Washington Investment Advisors Inc. OH Decreases Holdings - MarketBeat
Merck & Co., Inc. $MRK Stock: Fort Washington Investment Advisors Inc. OH Decreases Holdings MarketBeat
Merck & Co., Inc. $MRK Stock Position Lessened by HBW Advisory Services LLC - MarketBeat
Merck & Co., Inc. $MRK Stock Position Lessened by HBW Advisory Services LLC MarketBeat
Merck & Co., Inc. $MRK Position Cut by Perpetual Ltd - MarketBeat
Merck & Co., Inc. $MRK Position Cut by Perpetual Ltd MarketBeat
Merck appoints Paul Diaz to its board of directors - The Globe and Mail
Merck appoints Paul Diaz to its board of directors The Globe and Mail
Merck & Co., Inc. $MRK Shares Sold by Godsey & Gibb Inc. - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Godsey & Gibb Inc. MarketBeat
Merck & Co., Inc. $MRK Stock: Cliftonlarsonallen Wealth Advisors LLC Cuts Holdings - MarketBeat
Merck & Co., Inc. $MRK Stock: Cliftonlarsonallen Wealth Advisors LLC Cuts Holdings MarketBeat
9,102 Merck & Co., Inc. $MRK Shares Acquired by Fragasso Financial Advisors Inc - MarketBeat
9,102 Merck & Co., Inc. $MRK Shares Acquired by Fragasso Financial Advisors Inc MarketBeat
Merck & Co., Inc. $MRK Stock Holdings Cut by Salem Investment Counselors Inc. - MarketBeat
Merck & Co., Inc. $MRK Stock Holdings Cut by Salem Investment Counselors Inc. MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Sax Wealth Advisors LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Sax Wealth Advisors LLC MarketBeat
Merck & Co., Inc. $MRK Position Increased by NorthCrest Asset Manangement LLC - MarketBeat
Merck & Co., Inc. $MRK Position Increased by NorthCrest Asset Manangement LLC MarketBeat
48,205 Merck & Co., Inc. $MRK Shares Sold by Courier Capital LLC - MarketBeat
48,205 Merck & Co., Inc. $MRK Shares Sold by Courier Capital LLC MarketBeat
Our Q2 2026 financial results - Merck | Home
Our Q2 2026 financial results Merck | Home
Merck & Co., Inc. $MRK Holdings Increased by First Citizens Bank & Trust Co. - MarketBeat
Merck & Co., Inc. $MRK Holdings Increased by First Citizens Bank & Trust Co. MarketBeat
Merck & Co.’s Mission to Manufacture for Life - VEDP
Merck & Co.’s Mission to Manufacture for Life VEDP
Citigroup Forecasts Strong Price Appreciation for Merck & Co., Inc. (NYSE:MRK) Stock - MarketBeat
Citigroup Forecasts Strong Price Appreciation for Merck & Co., Inc. (NYSE:MRK) Stock MarketBeat
Merck Appoints Paul J. Diaz to Board of Directors - citybiz
Merck Appoints Paul J. Diaz to Board of Directors citybiz
Merck & Co., Inc. (NYSE:MRK) Stock Price Target Cut by Royal Bank Of Canada - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Price Target Cut by Royal Bank Of Canada MarketBeat
Analysts Are Bullish on These Healthcare Stocks: Merck & Company (MRK), Tarsus Pharmaceuticals (TARS) - The Globe and Mail
Analysts Are Bullish on These Healthcare Stocks: Merck & Company (MRK), Tarsus Pharmaceuticals (TARS) The Globe and Mail
Officials announce $2.9 billion from Merck to expand vaccine and medicine manufacturing in Montco - thereporteronline
Officials announce $2.9 billion from Merck to expand vaccine and medicine manufacturing in Montco thereporteronline
Merck Enters into Exclusive Global License Agreement with SciBrunch Therapeutics for SPR2015, an Investigational Oral KRAS G12D (ON) Inhibitor - Business Wire
Merck Enters into Exclusive Global License Agreement with SciBrunch Therapeutics for SPR2015, an Investigational Oral KRAS G12D (ON) Inhibitor Business Wire
Merck to Hold Third-Quarter 2026 Sales and Earnings Conference Call Oct. 29 - Business Wire
Merck to Hold Third-Quarter 2026 Sales and Earnings Conference Call Oct. 29 Business Wire
Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline - Business Wire
Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline Business Wire
Merck, Daiichi end plans to seek speedy approval of lung cancer ADC - BioPharma Dive
Merck, Daiichi end plans to seek speedy approval of lung cancer ADC BioPharma Dive